BLOGS & ARTICLES
Brain Scientific Announces Release of Improved NeuroCap(TM) and New US Distribution Deal with D&D Medical
Company Continues to Build Momentum as It Launches Its Disruptive Technologies in the Marketplace
Read MoreDaniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer
Company Continues to Build Momentum as It Launches Its Disruptive Technologies in the Marketplace
Read MoreBrain Scientific Announces CE Mark Approval for NeuroCap™ Device
The CE mark confirms that Brain Scientific meets all European Medical Device Directive requirements to begin commercializing its innovative neurological devices across the European Continent and other CE mark geographies.
Read MoreEEG For Sports Concussion Assessment
Long gone are the days when athletes were encouraged to shake off a concussion and get back to play as soon as possible. With so many children and teens playing contact sports, concussion has rightfully become an important public health issue. The American Academy of Neurology (AAN) describes concussion as “a form of mild traumatic brain injury (TBI)” and that it “is a common consequence of trauma to the head in contact sports.”
Read MorePediatric EEG: Meeting the Need through Innovative Technology
Children who present with altered mental status or possible seizures could be suffering from one of a number of causes. While EEG could help sort through that extensive differential, the practical barriers to EEG use in the emergency department or the PICU for diagnosticians to rely on indirect assessments. Fortunately, new technology is now available that allows EEG to be deployed rapidly and accurately in children and adolescents.
Read MoreBrain Scientific Announces Private Placement of $5.6 Million of Senior Secured Convertible Debentures and Warrants, Converts Approximately $12.9 Million of Existing Debt into Equity
Brain Scientific (OTCQB: BRSF) (the “Company”), a medical technology company with multiple patents and FDA-cleared products, today announces that it has entered into definitive agreements with certain institutional and accredited investors for the sale of senior secured convertible debentures and warrants to purchase shares of the Company’s common stock, resulting in total gross proceeds of approximately $5.1 million before deducting the placement agent’s fees and other offering expenses.
Read MoreExpedited EEG testing for Epilepsy
According to the World Health Organization, each year five-million people worldwide are diagnosed with Epilepsy, a neurological disorder that affects the brain. While there is no cure for epilepsy, early detection and treatment of seizures is critical for patient care. The WHO estimates up to 70% of people with epilepsy could live seizure-free if properly…
Read MoreAmbulatory EEG
Routine electroencephalography (EEG) suffers from the same problem as a standard 12 lead electrocardiogram (ECG): it is limited in time. A standard ECG captures 10 seconds of the heart’s electrical activity while a standard EEG captures perhaps 10 to 20 minutes of the brain’s electrical activity.
Read MoreBrain Scientific Announces First Quarter 2022 Results
LAKEWOOD RANCH, Fla., May 13, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Brain Scientific (OTCQB:BRSF) today reports its business highlights and financial results for the first quarter ended March 31, 2022.
Read MoreNATO Center of Excellence for Military Medicine to Study Brain Scientific’s NeuroCap Device
LAKEWOOD RANCH, Fla., May 04, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Brain Scientific (OTCQB:BRSF) today announces that its novel neurology products will be presented to the NATO Center of Excellence for Military Medicine as an innovative and potentially life-saving tool for armed service personnel.
Read More- « Previous
- 1
- 2
- 3
- Next »
NEUROLOGY NEWS
Brain Scientific and LOK Corporation Announce Global Partnership Advancing Innovative Neurodiagnostic Devices
"We believe that the NeuroCap and NeuroEEG have the potential to change the way EEGs are conducted and expand their application, and we are excited to be part of this endeavor."
Daniel Cloutier, CEO of LOK Corporation
Your questions are important to us.
Have a question? Contact Brain Scientific and a member of our team will reach back out to you.